For fund partners and operating teams. We assess companies with the diagnostic, then build and run AI systems and an AI C-Suite inside the companies your fund owns. Each company’s people stay in charge.
ProcessRoot assesses portfolio companies with the diagnostic, then designs, builds and runs AI systems and an AI C-Suite inside them, on one structure across the portfolio.
Each company’s people stay in charge of its decisions. The fund can have one operating rhythm and a view across the companies, on terms each company agrees.
How we work with a portfolio
Company by company. One structure.
The same approach we take with any business, organized for a fund: consistent across the companies, specific inside each one.
Assess a company
Before acquisition, with the access the seller and your deal team agree, or after closing. The diagnostic writes down where work piles up, where leadership time goes and what it would take to change it. It is an operating report, not a valuation or diligence.
Build inside each company
We build our systems and the AI C-Suite inside each company the fund owns, connected to that company’s own tools, with its management approving the permissions.
One operating rhythm
Each company in the program can receive the same weekly operating brief, built on one set of metric definitions, so revenue, cash, margin and exceptions are defined the same way across the portfolio.
An operating partner view
We build a cross-company view that compares the companies on consistent definitions and comparable periods, with access set by role.
Each company kept separate
Each company’s records are kept separate. Which measures the cross-company view includes is agreed in writing with your team and each company’s management before it is built.
Fund-level terms, company scopes
Terms can be set up for the fund or operating team, with a written scope, price and permissions for each company before its work begins.
Yes, with the access the seller and your deal team agree. The diagnostic is a written opportunity report. It is not a valuation, a quality-of-earnings review, legal diligence or investment advice.
Does the fund see each company’s data?
What the fund sees is agreed in writing with each company’s management before anything is built. Each company’s records are kept separate, and the cross-company view is limited to the measures in that agreement.
Who decides and who signs?
The people accountable in each company and at the fund. The AI roles prepare and recommend; they hold no title, signing authority or fiduciary duty.
Does it replace portfolio company management?
No. It adds capacity around each management team. Executives keep their roles, their judgment and their accountability.
Do we have to roll out to every company?
No. Start with one company and add others when the value is clear. Each company has its own scope.
Can it run on private models?
Yes. Private models are available on any package that builds or runs agents, hosted and managed by ProcessRoot on our infrastructure or in dedicated cloud environments, and quoted before you sign. The private route
What does it cost?
Each company is scoped after its diagnostic. Any fund-level terms, and each company’s scope and price, are written down and agreed before work begins.